Pharma Industry Outlook in 2015

Tougher competition and margin pressures create more challenges for the pharma industry in 2015. Changes in the payer landscape and practice centralization have turned pharmaceutical sales into an increasingly B2B sale that requires salespeople and com…

Biomedical Resource Workflow Tools

The biomedical research workflow is often a multi-dimensional process. Depending on the question you are trying to answer, the process my include surveying a new cell type or disease model to identify biologically relevant alterations or performing det…

Biomedical Resource Workflow Tools

The biomedical research workflow is often a multi-dimensional process. Depending on the question you are trying to answer, the process my include surveying a new cell type or disease model to identify biologically relevant alterations or performing det…

Generation of Induced Pluripotent Stem Cells

A comprehensive review of current state of the art practices for generating iPSCsExpert recommendations on which techniques to use for your specific purposes, including variations in reprogramming factors, delivery systems, and cell type…

Generation of Induced Pluripotent Stem Cells

A comprehensive review of current state of the art practices for generating iPSCsExpert recommendations on which techniques to use for your specific purposes, including variations in reprogramming factors, delivery systems, and cell type…

Top 5 Trends in the Pharmaceutical Industry in 2015

If the surge in TV commercials for prescription drugs is an indicator of the economic health of drug companies, then the pharmaceutical industry is indeed going strong. The industry’s advertising spending rose from $3.5 billion in 2012 to $4.5 billion …

A Road Map for Addressing Quality and Manufacturing Challenges in Life Sciences

This eBook dives deep into life science challenges and how leading organizations are approaching them. Specifically, it addresses:

  • How rising world populations and standards of living are increasing spending on healthcare.
  • Pressure of cGMP regulations from FDA and other regulatory bodies.
  • Organizations for approaching quality holistically rather than “as a department”.
  • Real-world examples of leading life science companies’ responses to regulation issues.
  • Benchmark data on how EQMS and MOM applications correlate to improvements in On-Tim Complete Shipments (OTCS), New Production Introduction (NPI), and Products in Compliance (PiC).
  • Recommended actions.

Request Free!

How Effective Training Management Can Help You Prevent Quality Issues

It’s not enough to have your quality standards on paper. You have to implement and integrate them into your daily operations and prove to regulators that your standards and policies work. “Effective training should be a fundamental part of a company’s quality management strategy as it can help prevent many quality problems from ever occurring,” said Hunter.

In a regulated environment, training is a means to minimize (if not avoid) human error, a common cause of deviations and nonconformances. It’s no wonder that various standards and regulations, such as the following, require training as an integral part of the quality management system.

  • FDA 21 CFR Part 211.25 for pharmaceutical companies
  • FDA 21 CFR Part 820.25 for medical device manufacturers
  • ISO 9000 2000 for general manufacturers and other businesses
  • ISO 13485 for medical device manufacturers

Request Free!

Top 5 Trends in the Pharmaceutical Industry in 2015

If the surge in TV commercials for prescription drugs is an indicator of the economic health of drug companies, then the pharmaceutical industry is indeed going strong. The industry’s advertising spending rose from $3.5 billion in 2012 to $4.5 billion …